Clinical trial
Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO
NCT03815890
Study timeline
Study start (actual)2019-10-04Date precision: day
Registry last updated2024-05-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
NivolumabDRUG · verified · RxNorm: nivolumab
IpilimumabDRUG · verified · RxNorm: ipilimumab
IpilimumabDRUG · verified · RxNorm: ipilimumab
Sponsors & collaborators
The Netherlands Cancer Institutelead sponsor
Bristol-Myers Squibbcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03815890 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.